Apollo Care, LLC recalls SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only
Recalled August 19, 2026 · FDA recall D-0754-2026 · Apollo Care
Hazard
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material · FDA Class II
Units
250 vials.
Sold at
Nationwide within the U.S
Description
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Product
SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202.NDC 71170-712-03
Manufacturer(s)
Apollo Care, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →